TMEM106B and Alzheimer disease: TMEM106B expression can be reduced in the brains of AD patients [26], and some studies have shown that loss of TMEM106B can induce severe lysosomal abnormalities in neurodegenerative models, especially in the context of PGRN loss [21,36,59].